Replies to post #17846 on Intellect Neurosciences Inc. (fka ILNS)

[itwillgetbetter]

Well here is a interesting story regarding Tau out today.

https://www.yahoo.com/health/were-we-getting-alzheimers-wrong-new-study-could-114577657447.html

Seems Tau is hot!Don't know but just maybe big pharma wanted Intellect to do this next study or others wanted to be apart with Intellect regarding Tau.

This month, Intellect initiated a sponsored research collaboration with one of the foremost Alzheimer's disease research centers in the United States to examine the detailed molecular mechanism affecting propagation of tau pathology. The sponsored research collaboration is to support our efforts to develop our TauC3 monoclonal antibody as a therapeutic treatment for Alzheimer's disease and other tauopathies.


By the way Elliot making this statement in the update was the key and very bold.

Shire has not identified any safety issues that would preclude further development of SHP622 for Friedrich's Ataxia.